Litigation Details for Forest Laboratories LLC v. Accord Healthcare Inc. (D. Del. 2015)
✉ Email this page to a colleague
Forest Laboratories LLC v. Accord Healthcare Inc. (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-03-27 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 7,834,020; 8,193,195; 8,236,804; 8,673,921 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Forest Laboratories LLC v. Accord Healthcare Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Forest Laboratories LLC v. Accord Healthcare Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-11-21 | 105 | .S. Patent Nos. 7,834,020 ("the '020 patent"), 8,193,195 ("the '195 patent"…that because claim 1 of U.S. Patent No. 7,834,020, claim 1 of U.S. Patent No. 8,236,804, and claims 5,… ORDER CONSTRUING THE TERMS of U.S. Patent Nos. 7,834,020, 8,193,195, 8,236,804, and 8,673,921. Signed…CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,834,020, 8,193,195, 8,236,804, AND 8,673,921 …in the patent. '020 patent, col. 27 ll.42-43; '804 patent, col. 28, 1. 1; '921 patent, col. | External link to document | |
| 2015-03-27 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,834,020; 8,193,195; 8,236,804… 27 March 2015 1:15-cv-00272-GMS Patent None District Court, D. Delaware | External link to document | |
| 2016-06-22 | 86 | other disorders. The patents-in-suit are U.S. Patent Nos. 7,834,020 (the “ ’020 patent”), 8,193,195 (the…the “ ’195 patent”), 8,236,804 (the “ ’804 patent”), and 8,673,921 (the “ ’921 patent”). While Forest … the ’020 patent, claim 1 of the ’804 patent, and claims 5, 11, and 13 of the ’921 patent, “crystalline…admits that a prior art patent, U.S. Patent No. 5,532,241 (the “ ’241 patent”), discloses vilazodone …804 Patent. The PTO rejected claim 1 of the ’804 patent as anticipated by the ’241 patent. See | External link to document | |
| 2016-06-22 | 87 | licensee of U.S. Patent Nos. 7,834,020 (“the ’020 patent”); 8,193,195 (“the ’195 patent”); 8,236,804 (“…(“the ’804 patent”); and 8,673,921 (“the ’921 patent”) (collectively, “the patents-in-suit”), which are… U.S. Patent No. 5,532,241 (“’241 patent”), which is incorporated by reference in the patents-in- …Merck Patent Gesellschaft mit beschränkter Haftung (collectively, “Merck”). The patents-in-suit…including major 1 The patents-in-suit all claim priority to a June 2001 patent application. | External link to document | |
| 2016-06-22 | 88 | infringed U.S. Patent Nos. 7,834,020 (the “’020 patent”), 8,193,195 (the “’195 patent”), 8,236,804 (the…22/16 Page 2 of 18 PageID #: 768 patent”) (collectively, “patents-in-suit”), by filing Abbreviated New… not present. VII. THE PATENTS-IN-SUIT 27. The patents-in-suit describe the invention…., ‘804 patent, col. 2, l. 39 to col. 3, l. 30; col. 5, ll. 1-22. Additionally, during patent prosecution…Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Attachments | External link to document | |
| 2016-07-27 | 93 | drug Viibryd®. The patents-in-suit are U.S. Patent Nos. 7,834,020 (the “ ’020 patent”), 8,193,195 (the…the “ ’195 patent”), 8,236,804 (the “ ’804 patent”), and 8,673,921 (the “ ’921 patent”), which all relate…administering” ’804 patent, claim 1 ’921 patent, claims 10, 12- …07/27/16 Page 13 of 27 PageID #: 1000 patent – U.S. Patent No. 5,532,241 of Bottcher et al. (“Bottcher…of the ’094 Patent. Id. at *14-15. In this case, each of the patents-in-suit is titled | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
